A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.
Cantisani MC, Parascandolo A, Perälä M, Allocca C, Fey V, Sahlberg N, Merolla F, Basolo F, Laukkanen MO, Kallioniemi OP, Santoro M, Castellone MD.
Cantisani MC, et al. Among authors: fey v.
Oncotarget. 2016 May 10;7(19):28510-22. doi: 10.18632/oncotarget.8577.
Oncotarget. 2016.
PMID: 27058903
Free PMC article.